Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
BA Beutel Goodman U.S. Value Fund Glenn Fortin and Rui Cardoso | “Marsh & McLennan is the preeminent global commercial lines broker, offering a capital-light business structure with resilient recurring revenues. A recent industry derating driven by expectations of softer pricing has provided a highly favorable entry point.” | BULL | Q1 2026 Mar 31, 2026 | View Pitch |
Value Line Asset Allocation Fund Stephen E. Grant | “Marsh & McLennan was a detractor this quarter as the financial sleeve experienced overall relative performance issues. The managers retain the company for its durable franchise and business stability.” | BULL | Q1 2026 Mar 31, 2026 | View Pitch |
The Bristol Gate U.S. Equity Strategy Achilleas Taxildaris | “Marsh & McLennan was sold amid a softening insurance rate environment and slowing consulting demand due to macro uncertainty. Declining commercial insurance pricing pressures near-term cash flows and dividend growth. BSD Analysis: MMC's operating leverage to commercial insurance pricing leaves it vulnerable to cyclical downturns. While a premier broker with high recurring revenue, the soft pricing cycle and discretionary consulting weakness justify a tactical exit. Dividend growth likely slows until pricing recovers.” | BEAR | Q3 2025 Sep 30, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
